Skip to main content

Table 1 Baseline Sociodemographic and Clinical Characteristics of HIV-positive Individuals Who Initiated HAART at Baseline vs. Those Who Did Not Initiate HAART at Baseline

From: Determinants of Treatment Access in a Population-based Cohort of HIV-positive Men and Women Living in Argentina

 

HAART Initiation

 

Variable

No (n = 188)

Yes (n = 648)

P value

Sex

Male

140 (74)

444 (69)

.15

Female

48 (26%)

202 (31%)

 

Age† (years)

33 (26.5–39)

36 (31–43)

<.001

MSM (n = 263)*

No

117 (62%)

456 (70%)

.03

Yes

71 (37)

192 (30)

 

IDU (n = 109)*

No

173 (92%)

554 (85%)

.02

Yes

15 (8%)

94 (15%)

 

Heterosexual transmission (n = 426)*

No

97 (52)

313 (48)

.43

Yes

91 (48)

335 (52)

 

Prior AIDS-defining illness*

No

176 (94)

426 (66)

<.001

Yes

12 (6)

222 (34)

 

CD4† (cells/mcL)

468 (316–700)

133 (48–255)

<.001

HIV RNA† (copies/mL)

17,197 (4651–55,396)

68,505 (7370–236,000)

<.001

  1. *Number (percentage)
  2. †Median (interquartile range)
  3. HAART = highly active antiretroviral therapy; IDU = injection drug use; mcL = microliter; MSM = men who have sex with men